These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1442921)

  • 1. Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome.
    Steege JF; Stout AL; Knight DL; Nemeroff CB
    Am J Obstet Gynecol; 1992 Jul; 167(1):168-72. PubMed ID: 1442921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes.
    Rojansky N; Halbreich U; Zander K; Barkai A; Goldstein S
    Gynecol Obstet Invest; 1991; 31(3):146-52. PubMed ID: 1649111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of [3H]paroxetine to serotonin uptake sites and of [3H]lysergic acid diethylamide to 5-HT2A receptors in platelets from women with premenstrual dysphoric disorder during gonadotropin releasing hormone treatment.
    Bixo M; Allard P; Bäckström T; Mjörndal T; Nyberg S; Spigset O; Sundström-Poromaa I
    Psychoneuroendocrinology; 2001 Aug; 26(6):551-64. PubMed ID: 11403977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder.
    Halbreich U; Petty F; Yonkers K; Kramer GL; Rush AJ; Bibi KW
    Am J Psychiatry; 1996 May; 153(5):718-20. PubMed ID: 8615423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes.
    Halbreich U; Piletz JE; Carson S; Halaris A; Rojansky N
    Biol Psychiatry; 1993 Nov; 34(10):676-86. PubMed ID: 7904832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lower insulin-like growth factor-1 concentrations in women with premenstrual dysphoric disorder.
    Thys-Jacobs S; McMahon D; Bilezikian JP
    Am J Obstet Gynecol; 2008 May; 198(5):506.e1-8. PubMed ID: 18199422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity.
    Gurguis GN; Yonkers KA; Phan SP; Blakeley JE; Williams A; Rush AJ
    Biol Psychiatry; 1998 Oct; 44(7):600-9. PubMed ID: 9787884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blunted serotonin response to fenfluramine challenge in premenstrual dysphoric disorder.
    FitzGerald M; Malone KM; Li S; Harrison WM; McBride PA; Endicott J; Cooper T; Mann JJ
    Am J Psychiatry; 1997 Apr; 154(4):556-8. PubMed ID: 9090347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonergic function and late luteal phase dysphoric disorder.
    Veeninga AT; Westenberg HG
    Psychopharmacology (Berl); 1992; 108(1-2):153-8. PubMed ID: 1410137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered sensitivity to alcohol in the late luteal phase among patients with premenstrual dysphoric disorder.
    Nyberg S; Wahlström G; Bäckström T; Sundström Poromaa I
    Psychoneuroendocrinology; 2004 Jul; 29(6):767-77. PubMed ID: 15110926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
    Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
    Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating insulin and leptin in women with and without premenstrual disphoric disorder in the menstrual cycle.
    Akturk M; Toruner F; Aslan S; Altinova AE; Cakir N; Elbeg S; Arslan M
    Gynecol Endocrinol; 2013 May; 29(5):465-9. PubMed ID: 23461756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet 3H-imipramine binding and familial transmission of affective disorders.
    Baron M; Barkai A; Gruen R; Peselow E; Fieve RR; Quitkin F
    Neuropsychobiology; 1987; 17(4):182-6. PubMed ID: 3441273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular and late luteal phase serum fluoxetine levels in women suffering from late luteal phase dysphoric disorder.
    Stewart DE; Fairman M; Barbadoro S; Zownir P; Steiner M
    Biol Psychiatry; 1994 Aug; 36(3):201-2. PubMed ID: 7948458
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls.
    Nyberg S; Andersson A; Zingmark E; Wahlström G; Bäckström T; Sundström-Poromaa I
    Psychoneuroendocrinology; 2005 Oct; 30(9):892-901. PubMed ID: 15979810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive flexibility, reaction time, and attention in women with premenstrual dysphoric disorder.
    Morgan M; Rapkin A
    J Gend Specif Med; 2002; 5(3):28-36. PubMed ID: 12078060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The late-luteal leptin level, caloric intake and eating behaviors among women with premenstrual dysphoric disorder.
    Ko CH; Yen CF; Long CY; Kuo YT; Chen CS; Yen JY
    Psychoneuroendocrinology; 2015 Jun; 56():52-61. PubMed ID: 25800149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonergic dysfunction in women with pure premenstrual dysphoric disorder: is the fenfluramine challenge test still relevant?
    Steiner M; Yatham LN; Coote M; Wilkins A; Lepage P
    Psychiatry Res; 1999 Oct; 87(2-3):107-15. PubMed ID: 10579544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased high affinity 3H-imipramine binding in platelets of enuretic children and adolescents.
    Weizman A; Carel C; Tyano S; Rehavi M
    Psychiatry Res; 1985 Jan; 14(1):39-46. PubMed ID: 3857647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with premenstrual dysphoric disorder have increased startle response across both cycle phases and lower levels of prepulse inhibition during the late luteal phase of the menstrual cycle.
    Kask K; Gulinello M; Bäckström T; Geyer MA; Sundström-Poromaa I
    Neuropsychopharmacology; 2008 Aug; 33(9):2283-90. PubMed ID: 17940552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.